Barrett & Company’s iShares iBonds Dec 2025 Term Corporate ETF IBDQ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-40,299
Closed -$1.02M 672
2025
Q3
$1.02M Buy
40,299
+66
+0.2% +$1.66K 0.35% 47
2025
Q2
$1.01M Buy
40,233
+64
+0.2% +$1.61K 0.38% 43
2025
Q1
$1.01M Sell
40,169
-195
-0.5% -$4.9K 0.43% 41
2024
Q4
$1.01M Buy
40,364
+80
+0.2% +$2K 0.43% 40
2024
Q3
$1.01M Sell
40,284
-341
-0.8% -$8.51K 0.44% 40
2024
Q2
$1.01M Buy
40,625
+66
+0.2% +$1.64K 0.46% 40
2024
Q1
$1.01M Buy
40,559
+104
+0.3% +$2.58K 0.48% 40
2023
Q4
$1M Sell
40,455
-381
-0.9% -$9.33K 0.54% 38
2023
Q3
$995K Buy
40,836
+3,066
+8% +$74.8K 0.59% 34
2023
Q2
$921K Sell
37,770
-15,490
-29% -$379K 0.53% 37
2023
Q1
$1.31M Buy
53,260
+7,674
+17% +$188K 0.83% 25
2022
Q4
$1.11M Hold
45,586
0.73% 30
2022
Q3
$1.11M Buy
+45,586
New +$1.12M 0.73% 30

Other funds holding IBDQ

Barrett & Company's IBDQ Position: Q4 2025 in Review

Barrett & Company sold out of iShares iBonds Dec 2025 Term Corporate ETF (IBDQ) in Q4 2025, closing a stake of 40,299 shares — an estimated $1.02M sold.

Barrett & Company first reported a position in IBDQ in Q3 2022 and held it in 13 quarters. The position peaked at $1.31M in Q1 2023. 3 funds tracked by Wall St. Rank hold IBDQ as of Q4 2025.

  • Barrett & Company reported no remaining iShares iBonds Dec 2025 Term Corporate ETF position as of Q4 2025 after selling out during the quarter.
  • Barrett & Company sold 40,299 iShares iBonds Dec 2025 Term Corporate ETF shares in Q4 2025, an estimated $1.02M.
  • Barrett & Company first reported a position in iShares iBonds Dec 2025 Term Corporate ETF in Q3 2022 and held it in 13 quarters.
  • Barrett & Company's iShares iBonds Dec 2025 Term Corporate ETF position peaked at $1.31M in Q1 2023.
  • 3 funds tracked by Wall St. Rank held iShares iBonds Dec 2025 Term Corporate ETF as of Q4 2025.

Based on Barrett & Company's 13F filing for Q4 2025, filed 28 Jan 2026.